CD38 and myelodysplastic syndrome: Notably, while symptoms such as anemia and thrombocytopenia can be attributed to the decrease of Lin−CD34+CD38+CD123−CD45RA− megakaryocyte erythroid progenitor (MEP), the phenotypic HSC are expanded in all types of MDS.